Product Description

Lupiparp 150mg Tablet contains olaparib, a targeted anticancer medicine belonging to the class of poly (ADP-ribose) polymerase inhibitors. PARP enzymes play an important role in repairing damaged DNA in cells. In cancer cells with specific genetic defects, such as BRCA gene mutations, this DNA repair process becomes essential for survival. Olaparib works by blocking PARP activity, leading to accumulation of DNA damage in cancer cells and ultimately causing cancer cell death while minimising harm to normal cells. Lupiparp 150mg Tablet is used as maintenance therapy or active treatment in ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer where PARP inhibition is clinically indicated. It is taken orally under the supervision of an oncology specialist as part of long-term cancer management.